Rami Komrokji: Our paper addressing pattern of lower risk myelodysplastic syndrome progression

Quoting Rami Komrokji, Vice Chair of the Malignant Hematology Department at Moffitt Cancer Centre and Research Institute, on X/Twitter:

”Early View / Hematologica our paper addressing pattern of LRMDS progression. Majority don’t progress and molecular signatures can identify direct AML progression.”